The Medical Cannabis Market Projected to Accelerate

NEW YORK, May 5, 2017 /PRNewswire/ --

New Frontier Data, a technology-driven analytics company specializing in the cannabis industry, indicates in a new report that in 2017, medical cannabis sales are forecast to grow to $5.3 billion or accounting for 67% of total cannabis sales. By 2025, current medical sales in legal states are forecast to grow to $13.2 billion, of which point medical sales will account for 55% of all sales. Comparatively, adult-use sales in 2017 are forecast to reach $2.6 billion, or rising to $10.9 billion by 2025. ChineseInvestors.com, Inc. (OTC: CIIX), Solis Tek Inc. (OTC: SLTK), Cannabis Sativa. Inc. (OTC: CBDS), Eco Science Solutions, Inc. (OTC: ESSI), United Cannabis Corporation (OTC: CNAB).

As for the hemp CBD Market, the Hemp Business Journal and Vote Hemp estimate in a new report that the total retail value of hemp products sold in the U.S. in 2016 was $688 million. Items like shelled seed, protein powder, soaps, lotions have continued to increase and complemented by successful hemp cultivation pilot programs in numerous states. In all, sales of Hemp CBD products boosted the industry to a five year 22% CAGR.

ChineseInvestors.com, Inc. (OTCQB: CIIX) announced earlier this week that it has appointed Summer (XiangYang) Yun as Chief Executive Officer (CEO) of its wholly-owned foreign entity, CBD Biotechnology Co., Ltd. XiBiDi Biotech's primary focus is online, retail and direct sales of hemp-based health products in China. Yun's initial focus will be the launch of 'CBD Magic Hemp Series' cosmetics line. He will also spearhead the Company's plan to import natural dietary supplements created using advanced extracting and purifying technologies into China. Yun is a marketing and branding executive with over 25 years of experience. Yun will report directly to CIIX's CEO Warren Wang.

"I am honored to be named as CEO of CBD Biotech," says Yun. "For over 5,000 years, hemp has been cultivated and used in over 25,000 products worldwide. CIIX has a unique opportunity to become one of the first companies to offer CBD-based skin care products in China online and through established retail and direct selling channels. Through the introduction of Magic CBD Series cosmetics to China, I hope to educate consumers regarding hemp's many benefits."

The CBD Magic Hemp Series line will include cleansers, moisturizing lotions and anti-aging products created using supercritical CO2 extraction technology. CBD Biotech also plans to launch a series of oral spray vitamins and supplements that can be used for relaxation, pain relief and sleep, among others things. Yun will oversee marketing and sales of these products in China, and utilizing his branding and marketing expertise, he will work to grow the CBD Biotech brand.

"I believe Yun is the perfect candidate to oversee CBD Biotech's operations. I am confident in his ability to introduce this revolutionary CBD-based skin care line to China and create and generate substantial revenue for CIIX," says Wang.

Solis Tek Inc. (OTCQB: SLTK) is a leading provider of digital lighting equipment for hydroponic cannabis cultivation. Using its proprietary technologies, the Company provides innovative aptitudes with its ballast, reflector and lamp products. On March 30, 2017, the company reported record revenues for the year ended December 31, 2016 of $8,563,751 compared to revenue of $7,713,456 in 2015. This represents an 11% increase in revenue over 2015. Gross profit for the years ended December 31, 2016 and 2015, was $3,123,859 and $2,719,036, respectively.

Cannabis Sativa. Inc. (OTCQB: CBDS) recently announced that it entered into an agreement to acquire the intellectual property for the White Rabbit brand of cannabis sprays and cannabis mints. The acquisition will include the exclusive and proprietary product formulations, product mixes, manufacturing methods and branding. The White Rabbit product line currently consists of fast acting low dose cannabis oral sprays and popular low dose cannabis mints. Both the spray and the mints are formulated as CBD only, THC only and CBD/THC blends. Dosage ranges include 2.5mg, 5mg and 10mg tablets and sprays with 1:1 and 20:1 variations of each.

Eco Science Solutions, Inc. (OTCQB : ESSI) recently announced that it has signed a Sponsorship, Content Development and Licensing agreement with Roaring Lion Tours, Inc. to develop unique educational content that brings awareness and education to the alternative medicine category. "There is a continuing need to bring awareness to the benefits of medical marijuana as a key category in the alternative medical health industry," stated Jeff Taylor, Chief Executive Officer of Eco Science Solutions, Inc. Mr. Taylor continued, "It is thrilling to be working with Stephen Marley and the team at Roaring Lion Tours, Inc. to fulfill our ongoing commitment in creating unique content that we can marry with our technologies to educate and inspire the world about alternative medicines."

On April 20, 2017, United Cannabis Corporation (OTCQB: CNAB) announced that it has entered into a Strategic Partnership with Advesa, a California Corporation ("Advesa"), to serve as its flagship product manufacturing facility in California for United Cannabis branded products and technologies. Advesa was designed and created by the Company's Chief Technology Officer, Tony Verzura, to facilitate the expansion of United Cannabis branded products, technologies, and its research and development activities for all global partnerships. Verzura commented on the announcement, "Since establishing a presence in California, we have worked tirelessly to build a strong product line and brand recognition for United Cannabis and our affiliates, Blue River, Prana, Bubbleman; collectively, these three brands have earned 23 medical cannabis awards including Best CBD Topical, Best THC Topical, Best CBD Concentrate, Best THC Concentrate, Highest Terpene Award, Best Vaporizer, and Best Non-Solvent Hash. Advesa will incorporate all of these technologies and brands in one facility, allowing us to expand across California, providing access to patients throughout the State."

Please Sign Up now at http://www.FinancialBuzz.com to receive alerts on trending Financial News from all these companies. "The Latest Buzz in Financial News"

Subscribe Now! Watch us report from NYSE https://www.youtube.com/FinancialBuzzMedia

Follow us on Twitter for real time Financial News Updates: https://twitter.com/financialbuzz

Follow and talk to us on Instagram: https://www.instagram.com/financialbuzz

Facebook Like Us to receive live feeds: https://www.facebook.com/Financialbuzz/

About FinancialBuzz.com

FinancialBuzz.com, a leading financial news informational web portal designed to provide the latest trends in Market News, Investing News, Personal Finance, Politics, Entertainment, in-depth broadcasts on Stock News, Market Analysis and Company Interviews. A pioneer in the financially driven digital space, video production and integration of social media, FinancialBuzz.com creates 100% unique original content. FinancialBuzz.com also provides financial news PR dissemination, branding, marketing and advertising for third parties for corporate news and original content through our unique media platform that includes Newswire Delivery, Digital Advertising, Social Media Relations, Video Production, Broadcasting, and Financial Publications.

Please Note: FinancialBuzz.com is not a financial advisory or advisor, investment advisor or broker-dealer and do not undertake any activities that would require such registration. The information provided on http://www.FinancialBuzz.com (the "Site") is either original financial news or paid advertisements provided [exclusively] by our affiliates (sponsored content), FinancialBuzz.com, a financial news media and marketing firm enters into service agreements with the companies which are the subject to the articles posted on the Site or other editorials for advertising such companies. We are not an independent news media provider and therefore do not represent or warrant that the information posted on the Site is accurate, unbiased or complete. FinancialBuzz.com receives fees for producing and presenting high quality and sophisticated content on FinancialBuzz.com along with other financial news PR media services. FinancialBuzz.com does not offer any personal opinions as we purely incorporate public market research along with financial and corporate news. FinancialBuzz.com only aggregates or regurgitates financial or corporate news through our unique financial newswire and media platform. We also do not include any personal opinions or commentary. For this release, FinancialBuzz.com expects to be compensated three thousand dollars for financial news dissemination and pr services by chineseInvestors.com inc. Our fees may be either a flat cash sum or negotiated number of securities of the companies featured on this site, or a combination thereof. The securities are commonly paid in segments, of which a portion is received upon engagement and the balance is paid on or near the conclusion of the engagement. FinancialBuzz.com has signed a two year agreement with chineseinvestors.com inc. for one hundred thousand restricted common shares for continued financial news dissemination and pr services. FinancialBuzz.com will always disclose any compensation in securities or cash payments for financial news PR advertising. FinancialBuzz.com does not undertake to update any of the information on the Site or continue to post information about any companies the information contained herein is not intended to be used as the basis for investment decisions and should not be considered as investment advice or a recommendation. The information contained herein is not an offer or solicitation to buy, hold or sell any security. FinancialBuzz.com, members and affiliates are not responsible for any gains or losses that result from the opinions expressed on the Site, company profiles, quotations or in other materials or presentations that it publishes electronically or in print. Investors accept full responsibility for any and all of their investment decisions based on their own independent research and evaluation of their own investment goals, risk tolerance, and financial condition. FinancialBuzz.com. By accessing this website and any pages thereof, you agree to be bound by the Terms of Use and Privacy Policy, as may be amended from time to time. None of the content issued by FinancialBuzz.com constitutes a recommendation for any investor to purchase, hold or sell any particular security, pursue a particular investment strategy or that any security is suitable for any investor. This publication is provided by FinancialBuzz.com. Each investor is solely responsible for determining whether a particular security or investment strategy is suitable based on their objectives, other securities holdings, financial situation needs, and tax status. You agree to consult with your investment advisor, tax and legal consultant before making any investment decisions. We make no representations as to the completeness, accuracy or timeless of the material provided. All materials are subject to change without notice. Information is obtained from sources believed to be reliable, but its accuracy and completeness are not guaranteed. For our full disclaimer, disclosure and Terms of Use, please visit: http://www.financialbuzz.com

For further information:
Media Contact:
info@financialbuzz.com
+1-877-601-1879

URL: http://www.FinancialBuzz.com

SOURCE FinancialBuzz.com